nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Pentoxifylline—systemic scleroderma	0.0616	0.14	CbGbCtD
Doxepin—CYP1A2—Leflunomide—systemic scleroderma	0.0588	0.133	CbGbCtD
Doxepin—ABCB1—Lisinopril—systemic scleroderma	0.0539	0.122	CbGbCtD
Doxepin—CYP2C9—Leflunomide—systemic scleroderma	0.053	0.12	CbGbCtD
Doxepin—ABCB1—Captopril—systemic scleroderma	0.0404	0.0914	CbGbCtD
Doxepin—CYP2D6—Captopril—systemic scleroderma	0.038	0.0861	CbGbCtD
Doxepin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0318	0.072	CbGbCtD
Doxepin—CYP2C19—Prednisone—systemic scleroderma	0.0315	0.0713	CbGbCtD
Doxepin—ABCB1—Prednisone—systemic scleroderma	0.0254	0.0575	CbGbCtD
Doxepin—HTR2B—cardial valve—systemic scleroderma	0.0252	0.258	CbGeAlD
Doxepin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.019	0.0431	CbGbCtD
Doxepin—CYP2C9—cardial valve—systemic scleroderma	0.0164	0.167	CbGeAlD
Doxepin—CYP3A4—Prednisone—systemic scleroderma	0.0152	0.0345	CbGbCtD
Doxepin—ABCB1—Methotrexate—systemic scleroderma	0.0127	0.0289	CbGbCtD
Doxepin—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00771	0.0786	CbGeAlD
Doxepin—HTR2A—pulmonary artery—systemic scleroderma	0.00546	0.0557	CbGeAlD
Doxepin—HRH2—skin of body—systemic scleroderma	0.0023	0.0235	CbGeAlD
Doxepin—CHRM5—skin of body—systemic scleroderma	0.0022	0.0224	CbGeAlD
Doxepin—HTR2A—artery—systemic scleroderma	0.00202	0.0206	CbGeAlD
Doxepin—HRH2—digestive system—systemic scleroderma	0.00184	0.0188	CbGeAlD
Doxepin—HTR2A—endothelium—systemic scleroderma	0.00171	0.0174	CbGeAlD
Doxepin—HTR2A—blood vessel—systemic scleroderma	0.00158	0.0161	CbGeAlD
Doxepin—HRH2—lung—systemic scleroderma	0.00154	0.0157	CbGeAlD
Doxepin—HTR2B—smooth muscle tissue—systemic scleroderma	0.00138	0.0141	CbGeAlD
Doxepin—HTR2B—skin of body—systemic scleroderma	0.00137	0.0139	CbGeAlD
Doxepin—CHRM3—smooth muscle tissue—systemic scleroderma	0.00125	0.0127	CbGeAlD
Doxepin—SLC6A4—digestive system—systemic scleroderma	0.0011	0.0112	CbGeAlD
Doxepin—HTR2B—digestive system—systemic scleroderma	0.00109	0.0111	CbGeAlD
Doxepin—ORM1—lung—systemic scleroderma	0.00108	0.011	CbGeAlD
Doxepin—HTR2B—tendon—systemic scleroderma	0.00104	0.0106	CbGeAlD
Doxepin—ABCB1—blood vessel—systemic scleroderma	0.00103	0.0105	CbGeAlD
Doxepin—CHRM3—digestive system—systemic scleroderma	0.000983	0.01	CbGeAlD
Doxepin—HRH1—connective tissue—systemic scleroderma	0.000967	0.00987	CbGeAlD
Doxepin—ADRA2A—connective tissue—systemic scleroderma	0.00095	0.00969	CbGeAlD
Doxepin—SLC6A4—lung—systemic scleroderma	0.000921	0.0094	CbGeAlD
Doxepin—CHRM1—lung—systemic scleroderma	0.000917	0.00936	CbGeAlD
Doxepin—CYP2C19—digestive system—systemic scleroderma	0.000914	0.00932	CbGeAlD
Doxepin—HTR2B—lung—systemic scleroderma	0.000913	0.00931	CbGeAlD
Doxepin—HRH1—smooth muscle tissue—systemic scleroderma	0.000885	0.00903	CbGeAlD
Doxepin—ADRA2C—tendon—systemic scleroderma	0.000818	0.00835	CbGeAlD
Doxepin—SLC6A2—lung—systemic scleroderma	0.000811	0.00827	CbGeAlD
Doxepin—HTR2A—connective tissue—systemic scleroderma	0.000808	0.00824	CbGeAlD
Doxepin—CYP1A2—digestive system—systemic scleroderma	0.000746	0.00761	CbGeAlD
Doxepin—HTR2A—smooth muscle tissue—systemic scleroderma	0.000739	0.00754	CbGeAlD
Doxepin—DRD2—lung—systemic scleroderma	0.000739	0.00754	CbGeAlD
Doxepin—ADRA2C—lung—systemic scleroderma	0.000718	0.00733	CbGeAlD
Doxepin—CYP2C9—digestive system—systemic scleroderma	0.000708	0.00723	CbGeAlD
Doxepin—HRH1—digestive system—systemic scleroderma	0.000699	0.00713	CbGeAlD
Doxepin—HRH1—tendon—systemic scleroderma	0.000665	0.00678	CbGeAlD
Doxepin—ADRA2A—tendon—systemic scleroderma	0.000653	0.00666	CbGeAlD
Doxepin—CYP1A2—lung—systemic scleroderma	0.000623	0.00636	CbGeAlD
Doxepin—HTR2A—digestive system—systemic scleroderma	0.000584	0.00595	CbGeAlD
Doxepin—HRH1—lung—systemic scleroderma	0.000583	0.00595	CbGeAlD
Doxepin—ADRA2A—lung—systemic scleroderma	0.000573	0.00585	CbGeAlD
Doxepin—HTR2A—tendon—systemic scleroderma	0.000555	0.00567	CbGeAlD
Doxepin—CYP3A4—digestive system—systemic scleroderma	0.00054	0.00551	CbGeAlD
Doxepin—CYP2D6—digestive system—systemic scleroderma	0.000532	0.00542	CbGeAlD
Doxepin—HTR2A—lung—systemic scleroderma	0.000487	0.00497	CbGeAlD
Doxepin—ABCB1—digestive system—systemic scleroderma	0.000382	0.0039	CbGeAlD
Doxepin—ABCB1—lung—systemic scleroderma	0.000319	0.00326	CbGeAlD
Doxepin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000631	CcSEcCtD
Doxepin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000627	CcSEcCtD
Doxepin—Hypotension—Lisinopril—systemic scleroderma	0.000288	0.000625	CcSEcCtD
Doxepin—Dizziness—Captopril—systemic scleroderma	0.000288	0.000625	CcSEcCtD
Doxepin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000622	CcSEcCtD
Doxepin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00062	CcSEcCtD
Doxepin—Urticaria—Leflunomide—systemic scleroderma	0.000285	0.000618	CcSEcCtD
Doxepin—Body temperature increased—Leflunomide—systemic scleroderma	0.000283	0.000615	CcSEcCtD
Doxepin—Abdominal pain—Leflunomide—systemic scleroderma	0.000283	0.000615	CcSEcCtD
Doxepin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000282	0.000612	CcSEcCtD
Doxepin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000611	CcSEcCtD
Doxepin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000611	CcSEcCtD
Doxepin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000611	CcSEcCtD
Doxepin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000281	0.000611	CcSEcCtD
Doxepin—Breast disorder—Methotrexate—systemic scleroderma	0.000281	0.00061	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000281	0.000609	CcSEcCtD
Doxepin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000609	CcSEcCtD
Doxepin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00028	0.000607	CcSEcCtD
Doxepin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00028	0.000607	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000607	CcSEcCtD
Doxepin—Insomnia—Lisinopril—systemic scleroderma	0.000279	0.000605	CcSEcCtD
Doxepin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000604	CcSEcCtD
Doxepin—Paraesthesia—Lisinopril—systemic scleroderma	0.000277	0.000601	CcSEcCtD
Doxepin—Vomiting—Captopril—systemic scleroderma	0.000277	0.000601	CcSEcCtD
Doxepin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000598	CcSEcCtD
Doxepin—Dyspnoea—Lisinopril—systemic scleroderma	0.000275	0.000596	CcSEcCtD
Doxepin—Rash—Captopril—systemic scleroderma	0.000274	0.000596	CcSEcCtD
Doxepin—Dermatitis—Captopril—systemic scleroderma	0.000274	0.000595	CcSEcCtD
Doxepin—Somnolence—Lisinopril—systemic scleroderma	0.000274	0.000595	CcSEcCtD
Doxepin—Headache—Captopril—systemic scleroderma	0.000273	0.000592	CcSEcCtD
Doxepin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000591	CcSEcCtD
Doxepin—Dyspepsia—Lisinopril—systemic scleroderma	0.000271	0.000589	CcSEcCtD
Doxepin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00027	0.000587	CcSEcCtD
Doxepin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00027	0.000587	CcSEcCtD
Doxepin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000586	CcSEcCtD
Doxepin—Asthma—Methotrexate—systemic scleroderma	0.000269	0.000584	CcSEcCtD
Doxepin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000582	CcSEcCtD
Doxepin—Decreased appetite—Lisinopril—systemic scleroderma	0.000268	0.000582	CcSEcCtD
Doxepin—Eosinophilia—Methotrexate—systemic scleroderma	0.000266	0.000578	CcSEcCtD
Doxepin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000266	0.000578	CcSEcCtD
Doxepin—Fatigue—Lisinopril—systemic scleroderma	0.000266	0.000577	CcSEcCtD
Doxepin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000577	CcSEcCtD
Doxepin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000575	CcSEcCtD
Doxepin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000574	CcSEcCtD
Doxepin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000264	0.000574	CcSEcCtD
Doxepin—Constipation—Lisinopril—systemic scleroderma	0.000263	0.000572	CcSEcCtD
Doxepin—Pain—Lisinopril—systemic scleroderma	0.000263	0.000572	CcSEcCtD
Doxepin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000572	CcSEcCtD
Doxepin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000569	CcSEcCtD
Doxepin—Bradycardia—Prednisone—systemic scleroderma	0.000262	0.000569	CcSEcCtD
Doxepin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000567	CcSEcCtD
Doxepin—Diarrhoea—Azathioprine—systemic scleroderma	0.00026	0.000564	CcSEcCtD
Doxepin—Nausea—Captopril—systemic scleroderma	0.000258	0.000561	CcSEcCtD
Doxepin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000559	CcSEcCtD
Doxepin—Asthenia—Leflunomide—systemic scleroderma	0.000257	0.000559	CcSEcCtD
Doxepin—Hallucination—Prednisone—systemic scleroderma	0.000256	0.000556	CcSEcCtD
Doxepin—Pancytopenia—Methotrexate—systemic scleroderma	0.000255	0.000555	CcSEcCtD
Doxepin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000254	0.000551	CcSEcCtD
Doxepin—Pruritus—Leflunomide—systemic scleroderma	0.000254	0.000551	CcSEcCtD
Doxepin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000253	0.00055	CcSEcCtD
Doxepin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000548	CcSEcCtD
Doxepin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000252	0.000547	CcSEcCtD
Doxepin—Dysuria—Methotrexate—systemic scleroderma	0.000251	0.000546	CcSEcCtD
Doxepin—Dizziness—Azathioprine—systemic scleroderma	0.000251	0.000545	CcSEcCtD
Doxepin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00025	0.000543	CcSEcCtD
Doxepin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000248	0.000538	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000534	CcSEcCtD
Doxepin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000245	0.000533	CcSEcCtD
Doxepin—Diarrhoea—Leflunomide—systemic scleroderma	0.000245	0.000533	CcSEcCtD
Doxepin—Urticaria—Lisinopril—systemic scleroderma	0.000245	0.000531	CcSEcCtD
Doxepin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000244	0.00053	CcSEcCtD
Doxepin—Abdominal pain—Lisinopril—systemic scleroderma	0.000244	0.000529	CcSEcCtD
Doxepin—Body temperature increased—Lisinopril—systemic scleroderma	0.000244	0.000529	CcSEcCtD
Doxepin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000526	CcSEcCtD
Doxepin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000242	0.000525	CcSEcCtD
Doxepin—Vomiting—Azathioprine—systemic scleroderma	0.000241	0.000524	CcSEcCtD
Doxepin—Pneumonia—Methotrexate—systemic scleroderma	0.000241	0.000524	CcSEcCtD
Doxepin—Eye disorder—Prednisone—systemic scleroderma	0.000241	0.000523	CcSEcCtD
Doxepin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000523	CcSEcCtD
Doxepin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000521	CcSEcCtD
Doxepin—Infestation—Methotrexate—systemic scleroderma	0.00024	0.000521	CcSEcCtD
Doxepin—Drowsiness—Methotrexate—systemic scleroderma	0.00024	0.000521	CcSEcCtD
Doxepin—Infestation NOS—Methotrexate—systemic scleroderma	0.00024	0.000521	CcSEcCtD
Doxepin—Rash—Azathioprine—systemic scleroderma	0.000239	0.00052	CcSEcCtD
Doxepin—Dermatitis—Azathioprine—systemic scleroderma	0.000239	0.000519	CcSEcCtD
Doxepin—Flushing—Prednisone—systemic scleroderma	0.000239	0.000519	CcSEcCtD
Doxepin—Headache—Azathioprine—systemic scleroderma	0.000238	0.000516	CcSEcCtD
Doxepin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000516	CcSEcCtD
Doxepin—Dizziness—Leflunomide—systemic scleroderma	0.000237	0.000515	CcSEcCtD
Doxepin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00051	CcSEcCtD
Doxepin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000234	0.000508	CcSEcCtD
Doxepin—Stomatitis—Methotrexate—systemic scleroderma	0.000234	0.000507	CcSEcCtD
Doxepin—Angiopathy—Prednisone—systemic scleroderma	0.000234	0.000507	CcSEcCtD
Doxepin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000506	CcSEcCtD
Doxepin—Immune system disorder—Prednisone—systemic scleroderma	0.000233	0.000505	CcSEcCtD
Doxepin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000501	CcSEcCtD
Doxepin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000501	CcSEcCtD
Doxepin—Arrhythmia—Prednisone—systemic scleroderma	0.00023	0.0005	CcSEcCtD
Doxepin—Sweating—Methotrexate—systemic scleroderma	0.00023	0.000499	CcSEcCtD
Doxepin—Vomiting—Leflunomide—systemic scleroderma	0.000228	0.000495	CcSEcCtD
Doxepin—Alopecia—Prednisone—systemic scleroderma	0.000228	0.000494	CcSEcCtD
Doxepin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000227	0.000493	CcSEcCtD
Doxepin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000227	0.000492	CcSEcCtD
Doxepin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000226	0.000491	CcSEcCtD
Doxepin—Rash—Leflunomide—systemic scleroderma	0.000226	0.000491	CcSEcCtD
Doxepin—Dermatitis—Leflunomide—systemic scleroderma	0.000226	0.00049	CcSEcCtD
Doxepin—Mental disorder—Prednisone—systemic scleroderma	0.000226	0.00049	CcSEcCtD
Doxepin—Nausea—Azathioprine—systemic scleroderma	0.000226	0.00049	CcSEcCtD
Doxepin—Headache—Leflunomide—systemic scleroderma	0.000225	0.000488	CcSEcCtD
Doxepin—Erythema—Prednisone—systemic scleroderma	0.000224	0.000487	CcSEcCtD
Doxepin—Malnutrition—Prednisone—systemic scleroderma	0.000224	0.000487	CcSEcCtD
Doxepin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000224	0.000486	CcSEcCtD
Doxepin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000483	CcSEcCtD
Doxepin—Asthenia—Lisinopril—systemic scleroderma	0.000221	0.00048	CcSEcCtD
Doxepin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000479	CcSEcCtD
Doxepin—Pruritus—Lisinopril—systemic scleroderma	0.000218	0.000473	CcSEcCtD
Doxepin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000217	0.000472	CcSEcCtD
Doxepin—Rash—Mycophenolic acid—systemic scleroderma	0.000216	0.000468	CcSEcCtD
Doxepin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000215	0.000468	CcSEcCtD
Doxepin—Hepatitis—Methotrexate—systemic scleroderma	0.000215	0.000467	CcSEcCtD
Doxepin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000466	CcSEcCtD
Doxepin—Headache—Mycophenolic acid—systemic scleroderma	0.000214	0.000465	CcSEcCtD
Doxepin—Pharyngitis—Methotrexate—systemic scleroderma	0.000214	0.000464	CcSEcCtD
Doxepin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000463	CcSEcCtD
Doxepin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000463	CcSEcCtD
Doxepin—Nausea—Leflunomide—systemic scleroderma	0.000213	0.000462	CcSEcCtD
Doxepin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000213	0.000462	CcSEcCtD
Doxepin—Vision blurred—Prednisone—systemic scleroderma	0.000211	0.000459	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—systemic scleroderma	0.000211	0.000458	CcSEcCtD
Doxepin—Diarrhoea—Lisinopril—systemic scleroderma	0.000211	0.000458	CcSEcCtD
Doxepin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000208	0.000452	CcSEcCtD
Doxepin—Anaemia—Prednisone—systemic scleroderma	0.000207	0.00045	CcSEcCtD
Doxepin—Agitation—Prednisone—systemic scleroderma	0.000206	0.000447	CcSEcCtD
Doxepin—Dizziness—Lisinopril—systemic scleroderma	0.000204	0.000442	CcSEcCtD
Doxepin—Nausea—Mycophenolic acid—systemic scleroderma	0.000203	0.000441	CcSEcCtD
Doxepin—Malaise—Prednisone—systemic scleroderma	0.000202	0.000439	CcSEcCtD
Doxepin—Vertigo—Prednisone—systemic scleroderma	0.000201	0.000437	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—systemic scleroderma	0.000201	0.000437	CcSEcCtD
Doxepin—Syncope—Prednisone—systemic scleroderma	0.000201	0.000437	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—systemic scleroderma	0.000201	0.000436	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—systemic scleroderma	0.0002	0.000434	CcSEcCtD
Doxepin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000432	CcSEcCtD
Doxepin—Loss of consciousness—Prednisone—systemic scleroderma	0.000197	0.000428	CcSEcCtD
Doxepin—Vomiting—Lisinopril—systemic scleroderma	0.000196	0.000425	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—systemic scleroderma	0.000195	0.000424	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—systemic scleroderma	0.000194	0.000422	CcSEcCtD
Doxepin—Rash—Lisinopril—systemic scleroderma	0.000194	0.000422	CcSEcCtD
Doxepin—Convulsion—Prednisone—systemic scleroderma	0.000194	0.000422	CcSEcCtD
Doxepin—Dermatitis—Lisinopril—systemic scleroderma	0.000194	0.000421	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000194	0.000421	CcSEcCtD
Doxepin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000421	CcSEcCtD
Doxepin—Hypertension—Prednisone—systemic scleroderma	0.000194	0.00042	CcSEcCtD
Doxepin—Chills—Methotrexate—systemic scleroderma	0.000193	0.000419	CcSEcCtD
Doxepin—Headache—Lisinopril—systemic scleroderma	0.000193	0.000419	CcSEcCtD
Doxepin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000415	CcSEcCtD
Doxepin—Arthralgia—Prednisone—systemic scleroderma	0.000191	0.000414	CcSEcCtD
Doxepin—Myalgia—Prednisone—systemic scleroderma	0.000191	0.000414	CcSEcCtD
Doxepin—Anxiety—Prednisone—systemic scleroderma	0.00019	0.000413	CcSEcCtD
Doxepin—Alopecia—Methotrexate—systemic scleroderma	0.00019	0.000413	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00019	0.000412	CcSEcCtD
Doxepin—Discomfort—Prednisone—systemic scleroderma	0.000189	0.000409	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—systemic scleroderma	0.000189	0.000409	CcSEcCtD
Doxepin—Erythema—Methotrexate—systemic scleroderma	0.000187	0.000407	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—systemic scleroderma	0.000187	0.000407	CcSEcCtD
Doxepin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000401	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—systemic scleroderma	0.000184	0.000398	CcSEcCtD
Doxepin—Nausea—Lisinopril—systemic scleroderma	0.000183	0.000397	CcSEcCtD
Doxepin—Oedema—Prednisone—systemic scleroderma	0.000183	0.000397	CcSEcCtD
Doxepin—Infection—Prednisone—systemic scleroderma	0.000182	0.000395	CcSEcCtD
Doxepin—Back pain—Methotrexate—systemic scleroderma	0.000181	0.000394	CcSEcCtD
Doxepin—Shock—Prednisone—systemic scleroderma	0.00018	0.000391	CcSEcCtD
Doxepin—Nervous system disorder—Prednisone—systemic scleroderma	0.000179	0.00039	CcSEcCtD
Doxepin—Tachycardia—Prednisone—systemic scleroderma	0.000179	0.000388	CcSEcCtD
Doxepin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000388	CcSEcCtD
Doxepin—Skin disorder—Prednisone—systemic scleroderma	0.000178	0.000386	CcSEcCtD
Doxepin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000177	0.000384	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—systemic scleroderma	0.000177	0.000383	CcSEcCtD
Doxepin—Anorexia—Prednisone—systemic scleroderma	0.000174	0.000379	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000174	0.000377	CcSEcCtD
Doxepin—Anaemia—Methotrexate—systemic scleroderma	0.000173	0.000376	CcSEcCtD
Doxepin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000373	CcSEcCtD
Doxepin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00037	CcSEcCtD
Doxepin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000369	CcSEcCtD
Doxepin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000367	CcSEcCtD
Doxepin—Malaise—Methotrexate—systemic scleroderma	0.000169	0.000367	CcSEcCtD
Doxepin—Vertigo—Methotrexate—systemic scleroderma	0.000168	0.000366	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—systemic scleroderma	0.000168	0.000364	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000167	0.000362	CcSEcCtD
Doxepin—Insomnia—Prednisone—systemic scleroderma	0.000166	0.000359	CcSEcCtD
Doxepin—Paraesthesia—Prednisone—systemic scleroderma	0.000164	0.000357	CcSEcCtD
Doxepin—Cough—Methotrexate—systemic scleroderma	0.000164	0.000355	CcSEcCtD
Doxepin—Convulsion—Methotrexate—systemic scleroderma	0.000162	0.000353	CcSEcCtD
Doxepin—Dyspepsia—Prednisone—systemic scleroderma	0.000161	0.00035	CcSEcCtD
Doxepin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000348	CcSEcCtD
Doxepin—Chest pain—Methotrexate—systemic scleroderma	0.00016	0.000346	CcSEcCtD
Doxepin—Myalgia—Methotrexate—systemic scleroderma	0.00016	0.000346	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—systemic scleroderma	0.00016	0.000346	CcSEcCtD
Doxepin—Decreased appetite—Prednisone—systemic scleroderma	0.000159	0.000345	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000158	0.000344	CcSEcCtD
Doxepin—Fatigue—Prednisone—systemic scleroderma	0.000158	0.000343	CcSEcCtD
Doxepin—Discomfort—Methotrexate—systemic scleroderma	0.000158	0.000342	CcSEcCtD
Doxepin—Constipation—Prednisone—systemic scleroderma	0.000156	0.00034	CcSEcCtD
Doxepin—Confusional state—Methotrexate—systemic scleroderma	0.000154	0.000335	CcSEcCtD
Doxepin—Infection—Methotrexate—systemic scleroderma	0.000152	0.00033	CcSEcCtD
Doxepin—Feeling abnormal—Prednisone—systemic scleroderma	0.000151	0.000327	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—systemic scleroderma	0.00015	0.000326	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00015	0.000325	CcSEcCtD
Doxepin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00015	0.000325	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—systemic scleroderma	0.000149	0.000323	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000148	0.000321	CcSEcCtD
Doxepin—Anorexia—Methotrexate—systemic scleroderma	0.000146	0.000317	CcSEcCtD
Doxepin—Urticaria—Prednisone—systemic scleroderma	0.000145	0.000316	CcSEcCtD
Doxepin—Abdominal pain—Prednisone—systemic scleroderma	0.000145	0.000314	CcSEcCtD
Doxepin—Body temperature increased—Prednisone—systemic scleroderma	0.000145	0.000314	CcSEcCtD
Doxepin—Hypotension—Methotrexate—systemic scleroderma	0.000143	0.00031	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000139	0.000303	CcSEcCtD
Doxepin—Insomnia—Methotrexate—systemic scleroderma	0.000138	0.0003	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—systemic scleroderma	0.000137	0.000298	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—systemic scleroderma	0.000136	0.000296	CcSEcCtD
Doxepin—Somnolence—Methotrexate—systemic scleroderma	0.000136	0.000295	CcSEcCtD
Doxepin—Hypersensitivity—Prednisone—systemic scleroderma	0.000135	0.000293	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—systemic scleroderma	0.000135	0.000292	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—systemic scleroderma	0.000133	0.000289	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000132	0.000287	CcSEcCtD
Doxepin—Fatigue—Methotrexate—systemic scleroderma	0.000132	0.000286	CcSEcCtD
Doxepin—Asthenia—Prednisone—systemic scleroderma	0.000131	0.000285	CcSEcCtD
Doxepin—Pain—Methotrexate—systemic scleroderma	0.000131	0.000284	CcSEcCtD
Doxepin—Pruritus—Prednisone—systemic scleroderma	0.000129	0.000281	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000126	0.000274	CcSEcCtD
Doxepin—Diarrhoea—Prednisone—systemic scleroderma	0.000125	0.000272	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000125	0.000272	CcSEcCtD
Doxepin—Urticaria—Methotrexate—systemic scleroderma	0.000121	0.000264	CcSEcCtD
Doxepin—Dizziness—Prednisone—systemic scleroderma	0.000121	0.000263	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—systemic scleroderma	0.000121	0.000262	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—systemic scleroderma	0.000121	0.000262	CcSEcCtD
Doxepin—Vomiting—Prednisone—systemic scleroderma	0.000116	0.000253	CcSEcCtD
Doxepin—Rash—Prednisone—systemic scleroderma	0.000115	0.000251	CcSEcCtD
Doxepin—Dermatitis—Prednisone—systemic scleroderma	0.000115	0.00025	CcSEcCtD
Doxepin—Headache—Prednisone—systemic scleroderma	0.000115	0.000249	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000113	0.000245	CcSEcCtD
Doxepin—Asthenia—Methotrexate—systemic scleroderma	0.00011	0.000238	CcSEcCtD
Doxepin—Nausea—Prednisone—systemic scleroderma	0.000109	0.000236	CcSEcCtD
Doxepin—Pruritus—Methotrexate—systemic scleroderma	0.000108	0.000235	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—systemic scleroderma	0.000105	0.000227	CcSEcCtD
Doxepin—Dizziness—Methotrexate—systemic scleroderma	0.000101	0.00022	CcSEcCtD
Doxepin—Vomiting—Methotrexate—systemic scleroderma	9.72e-05	0.000211	CcSEcCtD
Doxepin—Rash—Methotrexate—systemic scleroderma	9.64e-05	0.000209	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—systemic scleroderma	9.63e-05	0.000209	CcSEcCtD
Doxepin—Headache—Methotrexate—systemic scleroderma	9.58e-05	0.000208	CcSEcCtD
Doxepin—Nausea—Methotrexate—systemic scleroderma	9.08e-05	0.000197	CcSEcCtD
